A phase 1/2 dose escalation study of the oral DNA polymerase theta inhibitor (POLQi) GSK4524101 ± niraparib in adults with advanced or metastatic solid tumors.

SAIMIRULTEC CONSULTANCY PRIVATE LIMITED is a company registered in India on 23-04-2025 & Corporate Identification Number (CIN) is U62090TN2025PTC179670. SAIMIRULTEC CONSULTANCY PRIVATE LIMITED's ...

Pubaneswary Poobalan, a senior patient service associate at Singapore's National University Hospital, was fined for misusing the hospital's computer system to access confidential patient records. The ...

No further changes will be made to the Seoul Statement that came out of the Fourth Lausanne Congress on World Evangelization in Seoul, Korea, last year.

2.3. Test results This section provides an in-depth examination and discussion of the primary parameters for each specimen, encompassing failure modes, load-displacement curves, and load-strain curves ...

Physical fitness among Chinese college students has significantly declined over the past two decades, accompanied by marked increases in the burden of cardiovascular risks. There is an urgent need to ...

Poobalan: The statement is very clear that evangelism is absolutely important. We’re working away from old dichotomies that separate the message we proclaim from the lives we live.

The fifth one was Pannirselvam M S/O Malaiyandi. Curiously, there was one Nawas Khan and a K Sasikani who also contested as independents in the same seat.

First-in-human, phase 1/2 study of GSK4524101, an oral DNApolymerase theta inhibitor (POLQi), alone or combined with the poly (ADP-ribose) polymerase (PARP) inhibitor (PARPi) niraparib in adults with ...